Retrotransposition events have been well documented in yeast and Drosophila for many years. In these organisms much is known about the details of this mysterious biological phenomenon. In man, until recently we could only surmise that such events occurred, although the presence of highly repeated human elements with sequence homology to retrotransposons of other species strongly suggested their existence. In 1987 our lab found two instances of de novo retrotransposition of L1 sequences causing de novo hemophilia A in man. In this application we first propose to finish tracking the functional precursor of one of these elements and to describe thoroughly its subfamily and the subfamilies' evolution. We will then isolate the functional precursor of the second L1 element which retrotransposed and compare the structure of these two elements. These studies are critical to our knowledge of the biology and propagation of L1 elements. Second, we will use short oligonucleotide probes specific for each subfamily to search for new insertions in de novo cases of autosomal dominant and X-linked dominant disorders. We should be able to clone the gene for one of these disorders through use of the sequence flanking the inserted L1 element. Third, we will study the expression of the functional element found in the first aim in vivo and in vitro. We will discover whether element found in the first aim in vivo and in vitro. We will discover whether this sequence is transcribed after transfection in a """"""""natural state"""""""" without an overexpressing promoter, whether the open-reading frames are translated in cells, and whether the second open-reading frame can code for a natural reverse transcriptase. All of these studies should provide fundamental answers to questions as to how certain L1 elements act as retrotransposons.
The second aim should lead us to a novel scientific use of these rare events, the cloning of a hitherto unknown disease gene.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM045398-03
Application #
3304860
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1991-04-01
Project End
1994-05-31
Budget Start
1993-04-01
Budget End
1994-05-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Doucet-O'Hare, Tara T; Sharma, Reema; Rodi?, Nemanja et al. (2016) Somatically Acquired LINE-1 Insertions in Normal Esophagus Undergo Clonal Expansion in Esophageal Squamous Cell Carcinoma. Hum Mutat 37:942-54
Hancks, Dustin C; Kazazian Jr, Haig H (2012) Active human retrotransposons: variation and disease. Curr Opin Genet Dev 22:191-203
Goodier, John L; Mandal, Prabhat K; Zhang, Lili et al. (2010) Discrete subcellular partitioning of human retrotransposon RNAs despite a common mechanism of genome insertion. Hum Mol Genet 19:1712-25
Hancks, Dustin C; Kazazian Jr, Haig H (2010) SVA retrotransposons: Evolution and genetic instability. Semin Cancer Biol 20:234-45
Rangwala, Sanjida H; Kazazian Jr, Haig H (2009) The L1 retrotransposition assay: a retrospective and toolkit. Methods 49:219-26
Goodier, John L; Zhang, Lili; Vetter, Melissa R et al. (2007) LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol Cell Biol 27:6469-83
Kubo, Shuji; Seleme, Maria Del Carmen; Soifer, Harris S et al. (2006) L1 retrotransposition in nondividing and primary human somatic cells. Proc Natl Acad Sci U S A 103:8036-41
Farley, Alexander H; Luning Prak, Eline T; Kazazian Jr, Haig H (2004) More active human L1 retrotransposons produce longer insertions. Nucleic Acids Res 32:502-10
Deininger, Prescott L; Moran, John V; Batzer, Mark A et al. (2003) Mobile elements and mammalian genome evolution. Curr Opin Genet Dev 13:651-8